Identifying the culprit lesion in tumor induced hypophosphatemia, the solution of a clinical enigma

Author(s):
Slot-Steenks, M.M.B.; Hamdy, N.A.T.; Sande, M.A.J. van de; Vriens, D. (0000-0001-5762-6766); Cleven, A.H.G.; Appelman-Dijkstra, N.M.
Published
2016
Publication type
Article / Letter to editor
Tumor-induced osteomalacia (TIO)Fibroblast growth factor 23 (FGF23)Hypophosphatemia
Date issued
2016-12-31
Language
English
Is part of
Endocrine (2016), Vol. 54, no. 3, p. 642-647
hdl
1887/112389
doi
10.1007/s12020-016-1092-5